| Independent variables |
Tobacco dependence |
| Medium/ Low n(%) |
High n(%) |
Fisher’s test |
Unadjusted Odds Ratio |
Confidence interval 95% |
| Sex |
| Femalea |
25(42.4) |
34(57.6) |
0.182 |
0.62 |
0.27-1.43 |
| Male |
20(54) |
17(46) |
|
|
|
| Current age |
| Mean |
35.8 |
40.4 |
0.087b |
1.03 |
1.00-1.06 |
| Standard Deviation |
14.6 |
11.5 |
|
|
|
| Education |
| Up to Junior Higha |
26(51) |
25(49) |
0.257 |
1.42 |
0.63-3.19 |
| Above Junior High |
19(42.2) |
26(57.8) |
|
|
|
| Place of residence |
| Urbana |
39(44.3) |
49(55.7) |
0.097 |
0.27 |
0.05-1.39 |
| Rural |
6(75) |
2(25) |
|
|
|
| Time since diagnosis |
| Up to 4 yearsa |
27(55.1) |
22(44.9) |
0.074 |
1.98 |
0.88-4.46 |
| 4 years and over |
18(38.3) |
29(61.7) |
|
|
|
| Schizophrenia |
| Noa |
32(50) |
32(50) |
0.258 |
1.46 |
0.62-3.45 |
| Yes |
13(40.6) |
19(59.4) |
|
|
|
| Therapies received |
| Only clinicala |
17(39.5) |
26(60.5) |
0.137 |
0.58 |
0.26-1.32 |
| Other types |
28(52.8) |
25(47.2) |
|
|
|
| Previous hospitalization |
| Noa |
26(65) |
14(35) |
0.002 |
3.62 |
1.54-8.49 |
| Yes |
19(33.9) |
37(66.1) |
|
|
|
| 1st generation antipsychotics |
| Noa |
19(50) |
19(50) |
0.387 |
1.23 |
0.54-2.79 |
| Yes |
26(44.8) |
32(55.2) |
|
|
|
| 2nd generation antipsychotics |
| Noa |
30(53.6) |
26(46.4) |
0.089 |
1.92 |
0.84-4.40 |
| Yes |
15(37.5) |
25(62.5) |
|
|
|
| Somatic comorbidities |
| Noa |
25(56.8) |
19(43.2) |
0.053 |
2.15 |
0.94-4.90 |
| Yes |
19(38) |
31(62) |
|
|
|
| Age when smoking initiated |
| Up to 15 yearsa |
29(49.2) |
30(50.8) |
0.362 |
1.27 |
0.56-2.90 |
| 16 years and over |
16(43.2) |
21(56.8) |
|
|
|
| Attempted to quit smoking |
| Yesa |
37(45.7) |
44(54.3) |
0.395 |
0.74 |
0.24-2.22 |
| No |
8(53.3) |
7(46.7) |
|
|
|
aReference category
bt test for equality of means |
